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background: Feeder cells are frequently used for the early-stage of derivation and culture of human embryonic stem cell (hESC) lines.
methods: We established a conditionally immortalized human foreskin ﬁbroblast line that secreted basic ﬁbroblast growth factor (bFGF).
These cells were used as feeder cells for hESC culture and induced pluripotent stem (iPS) cell derivation and expansion. This conditional
immortalization was performed using lentiviral vector (LV) mediated transduction of Bmi-1 and human telomerase reverse transcriptase
genes and the resulting cell line was further modiﬁed by LV-mediated transduction of a secreted form of bFGF gene product. Three different
laboratories have tested whether this feeder cell line could support the maintenance of four different hESC lines.
results: Immortalized ﬁbroblasts secreting stable amounts of bFGF supported the growth of all hESC lines, which remained pluripotent
and had a normal karyotype for at least 10 passages. Even at high passage (p56), these modiﬁed cells, when used as feeders, could support
iPS derivation and propagation. Derived iPS cells expressed pluripotency markers, had hESC morphology and produced tissue components of
the three germ layers when differentiated in vitro.
conclusion: These modiﬁed ﬁbroblasts are useful as a genetically-deﬁned feeder cell line for reproducible and cost-effective culture of
both hESC and iPS cells.
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Introduction
Human embryonic stem cells (hESCs) are regarded as pluripotent
since they have the ability to differentiate into almost all cell types.
hESCs hold great promise for regenerative medicine and are a power-
ful tool for basic research (Thomson et al., 1998; Reubinoff et al.,
2000). Pluripotent hESC lines are derived from the inner cell mass
of surplus human blastocysts from day 5 to day 8 (Thomson et al.,
1998; Reubinoff et al., 2000; Hovatta et al., 2003; Inzunza et al.,
2005) or from 8-cell stage embryos (Strelchenko and Verlinsky,
2006). Conventionally, pluripotent hESCs are maintained directly on
co-cultured feeder layers derived from either mouse or human
sources (Reubinoff et al., 2000; Richards et al., 2002, 2003; Amit
et al., 2003; Hovatta et al., 2003; Choo et al., 2004). Human feeder
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cells also function in the derivation of hESC lines (Hovatta et al., 2003;
Inzunza et al., 2005) and in supporting hESC and induced pluripotent
stem (iPS) cell maintenance and propagation (Meissner et al., 2007;
Nakagawa et al., 2007, 2008; Yu et al., 2007; Hanna et al., 2008;
Lowry et al., 2008; Park et al., 2008). Of note, many groups have
used feeder free systems and added high concentration of ﬁbroblast
growth factor (bFGF) showing maintenance of hESC pluripotency
under these conditions (Wang et al., 2005a, b; Ludwig et al., 2006).
Self-renewal of both hESC and iPS cells are regulated by growth
factors and feeder cells in culture (Nichols et al., 1998). Regardless
of the source, feeders are derived from primary tissues and therefore
have a limited life span in culture. Moreover, hESC cannot maintain
pluripotency when co-cultured with mouse embryonic ﬁbroblast
(MEF) and human foreskin ﬁbroblast (HFF) feeders that reached
approximately 7–9 and 12–14 passages or more, respectively. There-
fore, fresh batches of feeders have to be prepared on a routine basis,
and then validated to account for batch-to-batch variation.
Immortalization of primary feeders would offer a possible solution
to this problem, resulting in a sustainable, standardized and consistent
source of feeders for the culture of hESC and iPS cells. Several
methods have been used previously for immortalization, including
the transduction of normal cells with simian virus 40 (SV40),
Epstein–Barr virus or human papillomavirus (Bryan and Reddel,
1994; Jha et al., 1998; Sugimoto et al., 1999; Gudjonsson et al.,
2002; Yamamoto et al., 2003). Recently, it was reported that the
overexpression of the human telomerase reverse transcriptase
(hTERT), can also extend the lifespan of somatic or differentiated
cells (Bodnar et al., 1998; Xu et al., 2004).
Currently, culture conditions with or without feeders are laborious,
time-consuming and/or expensive. There is also a need for large-scale
culture for the genetic manipulation of hESC and iPS cells in basic
research and for potential clinical applications. Until the optimal
recipe for animal substance-free, feeder-free and cost-effective
culture conditions is established, one possibility is to obtain Good
Manufacturing Practice (GMP)-grade immortalized human feeder
cells that can produce major growth factors such as bFGF, and to
maintain large-scale cultures of hESC and iPS cells in a pluripotent
and undifferentiated state, making stem cell research affordable.
Derivation of iPS cells from somatic cells such as mouse ﬁbroblasts
(Meissner et al., 2007; Nakagawa et al., 2007) and from fetal, neonatal
and adult human skin ﬁbroblasts (Takahashi et al., 2007; Yu et al.,
2007; Nakagawa et al., 2008; Park et al., 2008) represents a clear
breakthrough in regenerative medicine. Hence, it would be of great
interest to establish optimal feeder and culture conditions that allow
propagation and derivation of these pluripotent stem cells in clinically-
compatible conditions.
Here, we show (i) the generation and establishment of immortal
ﬁbroblast cells, (ii) their supportive ability for growth and expansion
of hESC lines and (iii) their potential for iPS cell derivation and propa-
gation in the undifferentiated stage.
Materials and Methods
Human ESC and HFF cell cultures
HFFs (CCL-110 and CCL-2429; ATCC, Manassas, VA, USA) were used to
prepare feeder dishes by inactivating the ﬁbroblast cultures (between
passages 4 and 10) mitotically using irradiation (35 Gy). Cells were
plated on 0.1% gelatin-coated (Sigma, Switzerland) culture dishes
(Nunclon, Roskilde, Denmark) at a density of 3.5  105 cells/cm2
(Inzunza et al., 2005). The feeder cell culture medium was Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing 2 mM glutamine, 50 U/ml
penicillin and 50 mg/ml streptomycin, 1  MEM-amino acids (ICN Biome-
dicals, USA), 1 mM sodium pyruvate (Sigma, Switzerland) and 10% FCS.
Feeder cell dishes were used within a week of plating. The original
culture medium was changed to stem cell medium just before ES or iPS
cells were added.
The hESC lines H1 and H9 from WiCell Research Institute Inc.
(Madison, WI, USA, www.wicell.org), VAL3 from the Spanish National
Stem Cell Bank (Prince Felipe Research Centre, Valencia, Spain) (Valbuena
et al., 2006) and the HS181 line from the Karolinska Institutet were culti-
vated by passaging colonies of hESC once every 5–6 days on irradiated
HFFs by means of mechanical dissociation. The propagation medium
was composed of DMEM/F-12 or Knockout DMEM (Gibco/BRL,
Paisley, Scotland, UK)þ20% serum replacement, 1% penicillin-
streptomycin, 1% non-essential amino acid (NEAA), b-mercaptoethanol
(Sigma-Aldrich GmbH, Buchs, Switzerland, www.sigmaaldrich.com),
L-glutamine and 4 or 20 ng/ml bFGF. All cell culture products were pur-
chased from Gibco (Invitrogen AG, Basel, Switzerland, www.invitrogen.
com) unless otherwise speciﬁed. Human ESC colonies were passaged
mechanically every 5–6 days. The four hESC lines were grown concur-
rently in different laboratories and the same batches of irradiated trans-
genic HFFs and control irradiated non-transduced HFFs were used. The
ratio of expansion was calculated by dividing the number of colonies in
Pþ1 by the number of colonies in P, where P refers to passage. Fragment
sizes obtained were similar in all four hESC lines, with 3–5 fragments from
every colony cut.
Lentiviral vector production and HFF
immortalization
The packaging constructs used in this study were the previously described
pCMVDR8.92 and the pCMVDR8.93 plasmids (Dull et al., 1998). The ves-
icular stomatitis virus G envelope was the pM2DG plasmid (Zufferey et al.,
1997). The pLOX-TERT-iresTK and pLOX-CWBmi1 expressing vectors
for immortalization were kindly donated by Didier Trono (Salmon et al.,
2000) and pWPI-bFGF-iresGFP by Jozef Kiss (Dayer et al., 2007). The
pXL-EF1-spFGF2-i2TK::Sh LV-vector was generated by replacing Green
Fluorescent Protein (GFP) with HSV1TK::ShBle fusion protein (originating
from plasmid pMOD-HSV1TKSH from InvivoGen, USA). Maps and
sequences of Lentiviral vectors (LVs) described in this study can be down-
loaded at http://medweb2.unige.ch/salmon/lentilab/.
Viral particles were produced using the transient transfection method
(Zufferey et al., 1997). A total of 293T cells (2.8  106 cells in 10-cm
tissue culture dishes) were co-transfected with either 10 mg of
pLOX-TERT-iresTK, 3.75 mg of pCMVDR8.92, 3.75 mg of pCMVDR8.93,
and 2.5 mg of pM2DG, or 10 mg of pLOX-CWBmi1, 3.75 mg of
pCMVDR8.92, 3.75 mg of pCMVDR8.93, and 2.5 mg of pM2DG, or
10 mg of pWPI_SPbFGF-iresGFP, 3.75 mg of pCMVDR8.92, 3.75 mg of
pCMVDR8.93, and 2.5 mg of pM2DG.
After transient transfection of the three plasmids in 293T cells by
calcium phosphate precipitation, the supernatant was harvested, concen-
trated by ultracentrifugation and re-suspended in serum-free Cellgro
medium (Boehringer Ingelheim Bioproducts, Heidelberg, Germany). Viral
stocks were stored at –708C. For immortalization, both LVs were
added to the HFF target cells in six-well plates (104 cells/well) at a multi-
plicity of infection (MOI) of 2, and vector particles were left on the cells for
3 days. All strategies and the molecular constructions are shown in Fig. 1A.
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Cloning of immortalized HFFs
After transduction, HFFs were clonally propagated and screened for Bmi
and hTERT expression. Clones stably expressing both genes were then
transduced at an MOI of 2 with LVs expressing bFGF either downstream
of the TK::Sh selectable marker (pXL-EF1-spFGF2-i2TK::Sh) or down-
stream of the GFP (pWPI-SPbFGF), and selected with either Zeocin
(InvivoGen, USA) or sorted for GFP ﬂuorescence, respectively. Immorta-
lized HFF expressing bFGF were then tested as feeders.
Throughout the text, HFFs transduced with pWPI_SPbFGF-iresGFP
will be referred to as ‘b-HFF’, HFFs transduced with pLOX-CWBmi
and pWPI_SPbFGF-iresGFP will be referred to as ‘Bb-HFF’, and
HFFs transduced with pLOX-CWBmi, pLOX-TERT-iresTK, and
pWPI_SPbFGF-iresGFP or pXL-EF1-spFGF2-i2TK::Sh will be referred to
as ‘I-HFF’.
HFF cell cycle
Normal and engineered HFFs were harvested and washed in 1 phos-
phate buffered saline (PBS), re-suspended in 500 ml 1 PBS containing
0.1% glucose and ﬁxed with 70% cooled ethanol. Florescent-activated
cell sorting (FACS) analysis was then performed after washing with PBS
and incubating with propidium iodide solution and RNase A at 378C for
45 min.
iPS generation and culture
Expression vectors of human Oct4, Sox2, Nanog and Lin28 genes were
kindly provided by Addgene. iPS generation and lentiviral production are
described elsewhere (Yu et al., 2007). Brieﬂy, after LV production, HFF
(CCL-110; ATCC, Manassas, VA, USA) were transduced with the four
reprogramming genes and plated over irradiated I-HFF cells that were at
passage 56. These cells were cultured in hESC culture medium. After
3 weeks, colonies with hESC morphology (iPS colonies) were isolated
mechanically for expansion without antibiotic selection. The ﬁrst two pas-
sages were mechanical, and then the enzymatic method using collagenase
(200 U/ml) for expansion. Up to seven distinct iPS cell lines were named
CHiPS 1–7 (CH stands for Confoederatio Helvetica).
Immunocytochemical analysis
Both undifferentiated hESC and iPS colonies were ﬁxed in 4% paraformal-
dehyde (PFA) and subsequently permeabilized with 0.5% Triton X-100.
After consecutive washing and blocking steps (using 5% bovine serum
albumin, BSA), the cells were incubated with the primary antibodies
SSEA-1 (1:25 dilution), SSEA-3 (1:50 dilution), SSEA-4 (1:50 dilution),
NANOG (1:50 dilution), TRA-1-60 (1:50), TRA-1-81 (1:50) and OCT-4
(1:50 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). FITC-
or TRITC-conjugated secondary antibodies were used for detection
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and nuclei were visual-
ized by DAPI staining (Sigma, Switzerland).
Flow cytometry analysis
Cells were washed twice with PBS and dissociated with TrypLE Express
(Invitrogen, USA) for ﬂow cytometry analysis. To remove the feeder
cells from hESC analysis, the mixed cell populations were seeded on
gelatin-coated wells and incubated for 2 h at 378C in standard hESC
medium. Non-attached hES cells were subsequently incubated for
20 min at 48C in DMEM containing 5% fetal bovine serum (FBS) with
the following monoclonal antibodies: stage-speciﬁc embryonic antigen-3
(SSEA3), tumor-rejection antigen-1-60 (Tra1-60) and SSEA1 (kindly pro-
vided by Mark Jones from the Peter Andrews Laboratory, University of
Shefﬁeld, Shefﬁeld, UK). The cells were incubated with the primary
antibody at 1:10 dilution followed by a secondary Cy5-conjugated
anti-rat IgM (for SSEA3) or anti-mouse IgG (for Tra1-60 and SSEA1) anti-
body (Chemicon, Temecula, CA, USA) at 1:200 dilution. Finally the cells
were washed twice in PBS, centrifuged at 300  g for 5 min, and
re-suspended in DMEM containing 5% FBS. Non-viable cells were ident-
iﬁed by their ability to incorporate propidium iodide (Sigma, Switzerland).
For SSEA-4 phenotypic monitoring, VAL-3 and H9 colonies were mechani-
cally dissected and dissociated to the single cell level with Accumax (Che-
micon, Temecula, CA, USA) solution at 378C. Cells were re-suspended to
approximately 3  105 cells per sample and prepared in duplicate. The
dissociated cells were then ﬁxed with 4% PFA, stained with the mouse
monoclonal anti-SSEA-4 (Chemicon, Temecula, CA, USA) at 1:300 and
incubated with the secondary antibody Alexa Fluor 488 anti IgG (Molecu-
lar Probes, Invitrogen, Carlsbad, CA, USA).
Flow cytometry analysis was performed on a FACSCalibur (BD Bio-
sciences, San Jose, CA, USA). Acquisition and analysis were performed
with BD CellQuestTM Pro (BD Biosciences) and FlowJo (Tree Star,
Ashland, OR, USA) software for SSEA3 and TRA-1-60 staining.
For SSEA-4 experiments, samples were analyzed with Cytomics CXP
software on a Beckman Coulter Cytomics FC500 (Beckman-Coulter, Full-
erton, CA, USA). Dead cells were excluded from acquisition using forward
scatter characteristics. Negative controls were included in each set of
experiments, foreskin ﬁbroblasts being used for the primary antibody
and isotype controls for secondary antibodies. All data were normalized
by dividing the test mean by the control mean using an electronic gate.
In-vitro and in-vivo characterization
of generated (iPS) cells
For in vitro characterization undifferentiated iPS cell colonies were trans-
ferred to suspension cultures and maintained in embryoid body (EB)
medium (KnockOut-DMEM, 20% FCS, 1% PEST, 1% Glutamax, 1%
NEAA, and 0.1 mM b-mercaptoethanol). EBs were cultured for
3 weeks in suspension cultures, after which half of the EBs were plated
in culture dishes coated with gelatin and grown in the presence of EB
medium and half were ﬁxed in 4% PFA for sectioning. For plated EBs,
the medium was changed every 2–3 days and after 14 days the cells
were ﬁxed in 4% PFA. For both experiments, cells were subjected to
immunohistochemical evaluation using primary antibodies directed
against a-smooth muscle actin, b-III-tubulin and Nestin (all from Santa
Cruz Biotechnology, USA). FITC-conjugated secondary antibodies were
used for detection (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
For the in-vivo characterization, 5 million of CH-iPS cells were collected
from I-HFF feeder layers by collagenase IV and were re-suspended in a
mixture of DMEM culture medium and Matrigel (ratio of 1:1). The cell mix-
tures were injected subcutaneously into ﬂanks of SCID mice. Tumors were
dissected from mice 5–8 weeks after injection and parafﬁn sections were
processed and stained with haematoxylin and eosin.
Karyotype of immortalized HFFs and hESCs
Karyotyping of H1, H9, HS181, VAL-3, iPS cells and the immortalized HFF
was performed by an independent laboratory in at least 20 metaphase
spreads, using the GTG-banding method (Genetic Service, Geneva
University Hospital, Switzerland).
Basic FGF secretion in the medium
For measurement of the secretion of bFGF by engineered HFFs, cells were
mitotically inactivated by irradiation in the same way as feeders used for
hESC culture and plated on 0.1% gelatin-coated (Sigma, Switzerland) culture
dishes (Nunclon, Roskilde, Denmark) at a density of 3.5  105 cells/cm2
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[normal cell concentration used for hESC culture system (Hovatta et al.,
2003)]. Engineered feeders were cultured in the presence of hESC
medium with or without bFGF. The medium was removed at several
time-points, and the amount of bFGF secreted was quantiﬁed with a stan-
dard ELISA detection method (Quantikine, R&D, USA).
RNA isolation and reverse transcription
Total RNA was extracted using a Total RNA Extraction Kit (Qiagen, Hom-
brechtikon, Switzerland) according to the manufacturer’s instructions for
small-scale quantities of cells, and RNA concentration was assessed with
a spectrophotometer (Biowave II, Biochrom, UK). Total RNA (1 mg)
from each sample was used for ﬁrst-strand cDNA synthesis with the
Advantage RT–PCR Kit (Clontech; BD Biosciences, Switzerland) following
the manufacturer’s protocol. The cDNA from each sample was used as a
PCR template to detect the expression of the genes listed in Table I. PCR
reaction mixtures were prepared with 1 mg total cDNA as the template,
and were then denatured at 948C for 4 min, and cycled 32 times at 948C
for 30 s, 55–608C for 30 s and 728C for 1 min. A ﬁnal extension at 728C
for 10 min was performed after cycling. PCR primers were designed with
Vector NTI freeware (Invitrogen) to show possible genomic contami-
nation. Negative control samples, including characteristic differentiation
genes from ectoderm, mesoderm and endoderm, were included in each
reaction. PCR products were resolved on 2% agarose gels, stained with
ethidium bromide and visualized in a transilluminator.
Results
LV-mediated conditional immortalization
of HFFs
The SV40 large T antigen (TAg) is extremely efﬁcient at achieving
immortalization, but induces a high degree of genetic instability that
rapidly leads to chromosomal aberrations and profound phenotypic
changes. In contrast, cells immortalized via the constitutive expression
of hTERT and Bmi were devoid of these problems; we thus decided to
Figure 1 Schematic for the generation of transgenic feeders.
(A) HFFs were immortalized using LV constructs expressing hTERT and Bmi. (B) Expression of Bmi and hTERT. Upon transduction, clonally expanded cell
lineswere screenedbyRT–PCR to select those that constitutively expressedBmi, hTERTorBmi–hTERT. Foreskin ﬁbroblasts expressing Bmior hTERT/Bmi
were then transduced with LV expressing bFGF fused to an Ig_Sp secretion signal sequence. Bmi and hTERT expression were analyzed by semi-quantitative
RT–PCR inHFF, Bb-HFF, I-HFF and hESCs. (C) Endogenous versus exogenous bFGF expression inHFF, Bb-HFF, I-HFF. (D) Immunoﬂuorescence staining of
bFGF expression in HFF and I-HFF (F) (transduced with pXL-EF1-spFGF2-i2TK::Sh), (E, G, I) DAPI staining, (H) negative control. Bar ¼ 20 mm.
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use the latter strategy (Cudre-Mauroux et al., 2003). For reversible
immortalization, commercially available HFFS and newly-derived fore-
skin ﬁbroblasts were transduced simultaneously with loxP-containing
human immunodeﬁciency virus (HIV)-derived LVs encoding hTERT
and/or Bmi1 polycomb ring ﬁnger oncogene (Bmi) (Fig. 1A). HFFs
transduced with a both LVs expressing hTERT and Bmi were subjected
to cloning by limiting dilution. Clones arising from this procedure were
screened for the presence of Bmi, TERT or Bmi/hTERT. Clones
expressing either Bmi or both hTERT and Bmi were randomly
selected, expanded, and further transduced with a LV expressing
basic bFGF together with eGFP living color (pWPI_SPbFGF lentivec-
tor), or TK::Sh (pXL-EF1-SPfgf2-i2TK::Sh)-selectable markers.
Notably, a secretion signal sequence was added to the coding
sequence of bFGF in both constructs, and the cells obtained were
polyclonal for bFGF expression and secretion.
To date, I-HFF cells have been maintained in culture for more than
1 year, namely more than 70 passages, which conﬁrms their immorta-
lized character. The LVs used in these experiments resulted in inte-
grants ﬂanked by loxP sites. As described previously for similarly
immortalized liver endothelial cells (Salmon et al., 2000), the addition
of Cre-recombinase led to the rapid growth arrest of these cells (data
not shown). This demonstrated that their continuous proliferation was
strictly dependent on the presence of immortalizing transgenes.
Indeed, semi-quantitative RT–PCR analysis conﬁrmed the presence
of Bmi and exogenous hTERT in I-HFF compared with hESC that
only express endogenous hTERT (Fig. 1B). Moreover, forced
expression of Bmi does not activate endogenous hTERT.
All generated cells, HFF (original foreskin ﬁbroblasts), Bb-HFF
(transduced with the LVs expressing Bmi and bFGF) and I-HFF (trans-
duced with the LVs expressing Bmi, hTERT and bFGF) were analyzed
by RT–PCR for exogenous and endogenous bFGF expression. The
HFF showed a basal expression of endogenous bFGF, whereas
Bb-HFF and I-HFF expressed both (Fig. 1C).
Immunocytochemical analysis showed the presence of bFGF in the
cytoplasm of HFF; in I-HFF, however, the expression of bFGF was
both nuclear and cytoplasmic (Fig. 1D–F).
Characterization of conditionally
immortalized HFFs
I-HFF showed an increased proportion of cells residing in the G2/M
phase of the cell cycle (Fig. 2A). When b-HFF and Bb-HFF were com-
pared with I-HFF at passage 20, the former two showed cell cycle
arrest and accumulation in the G0/G1 phase of the cell cycle
(Fig. 4E). Moreover, apart from I-HFF, all the other engineered cells
showed an increased rate of apoptosis.
A karyotype analysis conﬁrmed that I-HFF stably conserved the
diploid state of control primary cells at passage 40 this was also
stable in the hESC lines analyzed over the passages.
Using ELISA, we quantitatively assessed the time course secretion
of bFGF in the medium by cultured HFF, B-HFF, Bb-HFF and I-HFF.
Figure 2B showed that naı¨ve HFF had steady basal low secretion of
bFGF that did not exceeded 30 pg/ml. All transgenic feeders,
however, secreted high concentrations of bFGF that reached
340 pg/ml at day 6 in Bb-HFF cells (Fig. 2B). Analysis of bFGF
secretion by I-HFF and HFF in the presence of hESC did not reveal
any signiﬁcant difference between these two feeders (Fig. 2C).
However, the decreased level of bFGF after addition of exogenous
bFGF was signiﬁcantly slower in the supernatant of hESC cultured
on I-HFF than hESC cultured on HFF. H1 was also maintained and cul-
tured in an undifferentiated state longer over I-HFF than over HFF in
the absence of bFGF (Fig. 2D and E). Therefore, we decided to change
the culture medium by adding exogenous bFGF at 4 ng/ml every 48–
72 h as standard protocol for ESCs cultured on I-HFF.
Maintenance of pluripotency of various
human ESC lines
The four hESC lines H1, H9, HS181 and VAL-3 from three labora-
tories were cultured on mitotically-inactivated immortalized
bFGF-secreting feeder cells for 5–10 passages. Basic FGF was added
to the culture medium of the modiﬁed feeders only twice a week.
On these feeder cells, hESC lines H9 and HS181 maintained their
.............................................................................................................................................................................................
Table I Primers used for PCR and semi-quantitative RT–PCR analysis
Gene Sense primer (50 –30) Anti-sense primer (30 –50)
Oct3/4 GACAACAATGAAAATCTTCAGGAGA TTCTGGCGCCGGTTACAGAACCA
Nanog AAGACAAGGTCCCGGTCAAG CCTAGTGGTCTGCTGTATTAC
REX1 GCGTACGCAAATTAAAGTCCAGA CAGCATCCTAAACAGCTCGCAGAAT
hTERT CGGAAGAGTGTCTGGAGCAAGT GAACAGTGCCTTCACCCTCGA
PAX6 GAATCAGAGAAGACAGGCCA GAGTAGGTATCATAACTCCG
NESTIN GGCAGCGTTGGAACAGAGGTTGGA CTCTAAACTGGAGTGGTCAGGGCT
GATA4 CTGGCCTGTCATCTCACTACG GGTCCGTGCAGGAATTTGAGG
IHH CTACGCCCCGCTCACAAAG GGCAGAGGAGATGGCAGGAG
T(Brachyury) GCAAAAGCTTTCCTTGATGC ATGAGGATTTGCAGGTGGAC
AFP GGGAGCGGCTGACATTATTA CCCTCTTCAGCAAAGCAGAC
GAPDH AGCCACATCGCTCAGACACC GTACTCAGCGGCCAGCATCG
Endo-bFGF GCAAAAACGGGGGATTCTTCCTG TGCCCAGGTCCTGTTTTGGA
Exo-bFGF ATGAAATGCAGCTGGGTTATC TTGATGTGAGGGTCGCTCTT
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undifferentiated state at passages 32 and 42 signiﬁcantly longer than on
non-modiﬁed feeders, as shown in Fig. 3. The expansion ratios of
VAL-3 and H9 hESCs was higher on transgenic feeders than it was
on non-transgenic feeders (Fig. 3A and B) when cultured for up to
nine passages.
FACS analysis of H9 and HS181 lines after more than ﬁve passages
over HFF and I-HFF demonstrated stable expression of pluripotency
markers SSEA-3 and TRA 1-60 (Fig. 3E and G). In addition, both non-
modiﬁed and modiﬁed foreskin ﬁbroblasts also expressed SSEA-3, but
not TRA-1-60 (Fig. 3D and F). HS181 and H9 also showed typical
undifferentiating values for SSEA-4 staining by ﬂow cytometry (not
shown). All hESC colonies had typical undifferentiated ESC mor-
phology with sharp edges (Fig. 4A) and expressed OCT4 (Fig. 4B)
and NANOG, as revealed by immunoﬂuorescence (Fig. 4C).
A normal karyotype was detected in the hESC lines cultured on the
immortalized feeders (Fig. 4E–G).
Figure 2 (A) Cell cycle analysis of HFFs at passages 7, Bb-HFF at passage 20, b-HFF at passage 20 and I-HFF at passage 49.
About 60% of I-HFF cells were at G2/M phase, and they underwent less apoptosis at passage 49 when compared with HFF or Bb-HFF at passage 20.
The asterisk (*) indicates that the difference is statistically signiﬁcant (P, 0.05) when I-HFF was compared with the other cells. (B) ELISA assessment
of bFGF secretion by the different engineered HFFs. (C) ELISA assessment of bFGF content in I-HFF and HFF medium in the presence of hESC sup-
plemented or unsupplemented at t ¼ 0 with exogenous bFGF at a concentration of 4 ng/ml. (D) Comparison of H1 expansion when cultured over
HFF, b-HFF and I-HFF in the absence of bFGF. The same number of colonies was seeded over different feeders at the beginning of the experiment. As
for I-HFF, b-HFF maintained H1 for at least ﬁve passages, but HFF could not maintain H1 for more than three passages. (E) The percentage of undif-
ferentiated H1 colonies scored for ﬁve consecutive passages over HFF þ bFGF was signiﬁcantly different, whereas that for H1 over b-HFF and I-HFF þ
bFGF presented some random ﬂuctuations.
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Figure 3 Pluripotency maintenance of different hESCs.
(A) Ratio of expansion of VAL3 (B) and H9 when cultured over HFFs and I-HFF. (C) Flow cytometry analysis of SSEA-3 and Tra-1-60 expression in
HFF (D) and I-HFF (F) and in H9 (E) and HS181 (G) when cultured over HFF and I-HFF after more than ﬁve passages. The results showed a com-
parable level of expression of the pluripotency markers SSEA-3 and Tra-1-60 in both culture systems.
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Figure 4 (A) H1 hESCs morphology when grown over I-HFF feeders.
(B) Oct4 and (C) Nanog expression in H1 hESC growing over I-HFF cells as feeders. (D) DAPI staining. Bar ¼ 20 mm. (E) Karyotype at passage 40 of
immortalized feeders constitutively expressing Bmi and hTERT as well the secreted form of bFGF. Karyotype analysis of (F) H1 and (G) H9 after ﬁve
passages over the I-HFF.
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Generation and characterization of iPS
cells over I-HFF
The transduction of HFFs with LVs expressing Oct4, Nanog, Sox2 and
Lin28, and the plating over irradiated immortalized feeders at a high
passage (passage 56) proved successful. To facilitate observation of
the new iPS cell colonies, we generated I-HFF expressing both bFGF
and eGFP as a selection marker (Fig. 5C, F, I). Colonies formed by
small stem cell-like cells appeared on the feeders about 20 days post-
transduction (Fig. 5A, B, D, E). The small cells had typical hESC mor-
phology with a large nucleus and scanty cytoplasm (Fig. 5L). The ﬁrst
two mechanical passages resulted in round iPS cell colonies on the
feeders (Fig. 5G, K). Thereafter, enzymatic passage resulted in
similar morphology.
At passage seven, the colonies displayed a normal karyotype (data
not shown). When compared with the H1 hESC line, the majority of
derived iPS lines expressed endogenous pluripotency markers REX1,
SOX2, OCT4, NANOG, LIN28 (Fig. 6A). Moreover, despite the
viral genes Oct4, Nanog, Sox2 and Lin28 were integrated in the
genome of the different iPS lines (called CHiPS 1-7) as veriﬁed by
PCR (Fig. 6B), no expression from exogenous transgene was detected
by semi-quantitative PCR. Like CHiPS 4, 5, 7, the immunocytochem-
istry of CHiPS 6 showed the expression of OCT4, Nanog, SSEA4,
SSEA3 and TRA-1-61 proteins (Fig. 6C). To eliminate the possibility
that iPS cells were originally derived from I-HFF feeders which had
integrated the reprogramming viruses, we performed a PCR on
genomic DNA of CHiPS lines and showed that they did not contain
and had not integrated any of the immortalizing vectors, namely Bmi
and hTERT (Fig. 6D).
When differentiated into partially cystic EBs, tissue components
expressed markers of the three germ layers (Fig. 7A). EBs resulting
from different colonies of iPS cells expressed Nestin, GATA4, IHH,
AFP and CK3 markers as revealed by semi-quantitative RT–PCR
(Fig. 7B). CHiPS7, one of the cell sub-lines, also expressed Brachyury
(Fig. 7B). The expression of the markers representative of the three
germ layers, namely SMA, AFP and beta-3-tubulin, was demonstrated
by immunohistochemistry of CHiPS 7 (Fig. 7C), and by immunoﬂuor-
escence (Fig. 7D). Derived iPS cells also induced teratomas when
injected into immuno-suppressed SCID mice (data not shown).
Discussion
We established immortalized bFGF-secreting human skin ﬁbroblasts to
be used as feeder cells for hESC and iPS cells. The cells supported the
expansion of four different hESC lines in an undifferentiated state and
also allowed the growth and derivation of iPS cells originating from the
same parental ﬁbroblasts. Several hESC and newly-established iPS cell
lines were karyotypically normal after culture on these genetically
modiﬁed feeders. Human ESCs remained undifferentiated and pluripo-
tent on these feeders after 5–10 passages. These feeders thus offer a
new standardized and effective culture system for hESCs.
Several types of feeder cells have been successfully used for hESC
culture. At ﬁrst, MEFs were used (Thomson et al., 1998; Reubinoff
et al., 2000) followed by human fetal muscle and adult fallopian tube
ﬁbroblasts (Richards et al., 2002, 2003). HFFs were employed for
both culture of existing hESC lines (Amit et al., 2003) and derivation
of new ones (Hovatta et al., 2003). Fibroblasts differentiated from
hESCs have been successfully used as feeder cells by several groups
(Xu et al., 2004; Stojkovic et al., 2005; Wang et al., 2005a, b; Saxena
et al., 2008). Human placental ﬁbroblasts from early pregnancy were
also functional (Genbacev et al., 2005; Simon et al., 2005) and adult
bone marrow cells were employed by Cheng and colleagues (2003).
The number of different cell types used as feeders reﬂects the fact
that, although functional, none of these cell types as feeders have
been optimal. MEFs bear a risk of infection and immune response
(Martin et al., 2005), placental ﬁbroblasts are not easy to isolate, and
human skin cells vary in quality and do not support optimal growth
after 20 passages (Unger et al., 2008a). There is also large
batch-to-batch variation among these cell types (Eiselleova et al., 2008).
For the moment, bFGF remains a necessary growth factor for the
undifferentiated growth of hESCs (Amit et al., 2003; Koivisto et al.,
2004; Dvorak and Hampl, 2005). It regulates the expression of
TGFb1, Activin A and the BMP4 antagonist which are important for
hESC growth and self-renewal (Dvorak and Hampl, 2005; Greber
et al., 2006; Eiselleova et al., 2008). The fact that MEF and HFF lines
secrete varying amounts of bFGF (Eiselleova et al., 2008) may partially
explain why different batches of MEFs and HFFs support hESCs differ-
ently. Other growth factors such as Activin A and TGFb1 also play a
role (Eiselleova et al., 2008), and variability in the production of these
factors affects their ability to support hESCs. Cai and colleagues (2007)
generated immortalized feeder cells overexpressing Wnt3a that are
supportive of hESC expansion and pluripotency maintenance. One
ﬁbroblast-like feeder cell line which differentiated spontaneously
from hESCs supported hESC expansion particularly well (Saxena
et al., 2008) up to passage 15. By secreting relatively high amounts
of endogenous bFGF, these feeders required the addition of only
2 ng/ml bFGF to the culture medium instead of the usual concen-
trations of 4–20 ng/ml. In all cases, bFGF is expressed in its natural
form, i.e. mostly un-secreted and cytoplasmic.
Therefore, in our study, we added a secretion signal to the bFGF,
enabling its secretion, as demonstrated by Dayer and colleagues
(2007). Moreover, as we detected bFGF in both the nucleus and
the cytoplasm of I-HFF, we infer this by the existing sequence simi-
larities between the secretion signal (Ig_sp) and known nuclear local-
ization signals. As a result, our transduced immortalized bFGF-
producing feeders (I-HFF) expressed higher levels of bFGF which
were more suitable to hESC maintenance. Basic FGF is unstable in sol-
ution, which means that the medium has to be renewed daily to
achieve an optimal propagation; besides being expensive, this is labor-
ious and time-consuming. The use of bFGF-producing feeders standar-
dizes and decreases the cost of cultures. By selecting and screening the
best monoclonal I-HFF cell line for the secretion of bFGF, we may
avoid the exogenous addition of this growth factor and will improve
the standardization of embryonic stem cell culture conditions.
Immortalization enables the use of the same feeder cell line for pro-
longed periods of time in more standardized culture conditions, a criti-
cal issue in the maintenance and stability of hESCs (Skottman and
Hovatta, 2006). Here we demonstrated that even at high passages
(p49) our feeders secreted high concentrations of bFGF although in
non-immortalized cells bFGF secretion decreased at much lower
passage levels. Since I-HFF were clonal after immortalization with
hTERT and Bmi and were not clonal for bFGF, a possible heterogen-
eity may explain the variation in its secretion. As a consequence, we
added bFGF twice a week in order to further standardize our
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culture conditions. Notably, almost no senescence or apoptosis was
seen in the immortalized bFGF-secreting feeders at passage 49,
which was in strong contrast to HFF and Bb-HFF.
Xeno-free feeders would be necessary for clinical tests and treat-
ment (Unger et al., 2008b). We have already established a system
for GMP-quality HFFs (Unger et al., 2008a) and a transduction
Figure 5 iPS cell generation over I-HFF (transduced with pWPI SPbFGF-iresGFP).
(A, B, D, and E) Morphology of reprogrammed colonies growing over I-HFF feeder cells. (C, F) Epiﬂuorescent pictures showing that I-HFF cells were
green ﬂuorescent, allowing the easy identiﬁcation of reprogrammed colonies. (G, H) Morphology of reprogrammed colony after the ﬁrst passage when
grown over I-HFF, (I) as shown with epiﬂuorescent microscopy. (J) Typical morphology of an established iPS colony (4  magniﬁcations). (K, L) iPS
cells displaying a hESC-like phenotype. Bar ¼ 20 mm.
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Figure 6 (A) Semi-quantitative RT–PCR expression proﬁle of different endogenous pluripotency markers expressed in iPS cells when derived over
the immortalized feeders.
Exogenous transgenes (Oct4, Nanog, Sox2) were not detected with semi-quantitative RT–PCR. (B) Integration of viral genes in genomic DNA of
derived iPS determined by PCR. (C) Immuno-ﬂuorescence staining of Oct4, Nanog, SSEA-3, SSEA-4 and Tra-1-60 in iPS cells derived using I-HFF
as feeders. Bar ¼ 20 mm. (D) Determination of integrated viral genes Bmi and hTERT in genomic DNA of I-HFF, HFF and CHiPS 4 and 7 by PCR.
Immortalized human skin ﬁbroblast feeder cells support growth and maintenance 2577
system similar to the one used in the present study can be applied to
generate GMP-quality feeder cells. Such a procedure is currently being
implemented.
Recently, the mechanisms governing the self-renewal of ESCs have
become clearer (Saxena et al., 2008). In the future, we may not
require feeder cell support to establish stable hESC lines. By efﬁciently
inhibiting differentiation during the propagation stage and releasing
them to differentiate when desired, we may be able to obtain standar-
dized controllable cells. Improved systems of feeder-free cultures are
also under development.
Two teams have succeeded in creating feeder-free derivations of
hESC lines. Klimanskaya and colleagues (2005) used a mouse-
derived matrix which was neither xeno-free nor deﬁned. Ludwig
and colleagues (2006) derived two hESC lines on human tissue-
derived ﬁbronectin and laminin and in chemically-deﬁned medium.
One of these lines was karyotypically abnormal (47,XXY) from
the beginning, and the other had gained an extra chromosome by
passage 40. Although the ﬁrst chromosomal abnormality may have
resulted from an abnormal embryo, it was hypothesized that feeder-
free conditions may promote culture adaptation of abnormal lines
Figure 7 (A) Embryoid bodies formed from CHiPS 7 colonies after expansion over I-HFF feeders and growth in suspension.
(B) Representative expression of three germ cell layers by semi-quantitative RT–PCR after 3 weeks of culture. (C) Immunohistological analysis of iPS
cell-derived EBs. (a) Negative control, (b) SMA, (c) AFP and (d) b3-tubulin staining. (D) iPS cell differentiation potential. iPS cells were cultured in
suspension as EB and plated over cover-slips coated with gelatin. As revealed by immunocytochemistry, differentiated cells expressed Nestin
(top), b3-tubulin (middle, indicated by arrow) and SMA (bottom). Nuclei are stained by DAPI. Bar ¼ 20 mm.
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(Draper et al., 2004). For the time being, the use of feeder cells is
still the safest and most cost-effective option to derive and propa-
gate stable hESCs. For this purpose, our immortalized
bFGF-producing foreskin ﬁbroblasts offer a standardized functional
solution, and the cells will be available to the scientiﬁc community.
For certain experiments such as genetic studies and the generation
of transgenic hESCs, feeder-free cultures are superior to co-cultures
on feeders. Conversely, feeders offer a safe and cost-effective
culture method for culturing and maintaining stable hESCs and for
banking them.
Importantly, we also achieved the transduction of HFFs by over-
expressing OCT4, SOX2, NANOG and LIN28 (Yu et al., 2007).
The transduction procedure using non-replicating LVs proved success-
ful in our laboratory. Even at passage 56 the immortalized
bFGF-producing feeders appeared to support the growth of our iPS
cell colonies very well.
Conclusion
We established the ﬁrst well-functioning immortalized
bFGF-producing foreskin ﬁbroblast cell line. Although they have
great potential as feeders for maintaining different pluripotent hESC
lines, these conditionally immortalized foreskin ﬁbroblasts proved to
be useful for the derivation and the culture of iPS cell lines even at
passage 56. Further studies are needed to determine whether the
conditioned medium of these modiﬁed feeders can maintain hESC
pluripotency in feeder-free culture conditions and improve reprogram-
ming efﬁciency.
Figure 7 Continued
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